Regulatory Rapporteur May 2020
FOCUS: Healthcare regulatory affairs in China PLUS: • Letters: Regulators united in fight against COVID-19 • Meeting report: Drug repurposing for rare diseases • Devices: Latest medical device standards update
Regulatory Rapporteur May 2020MEMBERS
Medical device standards updateMEMBERS
Advantages of major new legislation for product registration in ChinaMEMBERS
Reforms to improve and strengthen China's drug regulatory policyMEMBERS
Updates to China's drug registration regulations and their impact on industryMEMBERS
The effects of new drug legislation on China's market and pharma industryMEMBERS
Integrating regulatory information for greater efficiency and cost savingsMEMBERS
Interview: ITLV/EUnetHTA - Goals for health technology assessment in SwedenMEMBERS
Meeting report: Drug repurposing for rare diseases PUBLIC
Letter: Regulators are mounting a concerted effort against COVID-19 – will it be enough? PUBLIC
Editorial: Examining China's regulatory reform PUBLIC